Cost-effectiveness analysis of strategies for diagnosing celiac disease

Digestive Diseases and Sciences

Volumn 53, Issue 3, 2008, Pages 680-688

  Dorn, Spencer D ^a   Matchar, David B ^b,c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Celiac disease; Cost effectiveness; Diagnosis

Indexed keywords

HLA DQ ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ARTICLE; CELIAC DISEASE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC PROCEDURE; ESOPHAGOGASTRODUODENOSCOPY; HUMAN; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY;

CELIAC DISEASE; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; IMMUNOGLOBULIN A; PREDICTIVE VALUE OF TESTS; SEROLOGIC TESTS;

EID: 39849085201     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9939-5     Document Type: Article

References (39)

1. James SP (2005) This month at the NIH: final statement of NIH consensus conference on celiac disease. Gastroenterology 128:6
2. Green PH, Jabri B (2003) Coeliac disease. Lancet 362:383-391
3. Rostom A, Murray JA, Kagnoff MF (2006) American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131:1981-2002
4. Cataldo F, Lio D, Marino V, Picarelli A, Ventura A, Corazza GR (2000) IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 47:366-369
5. Zarkadas M, Cranney A, Case S et al (2006) The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet 19:41-49
6. Burgin-Wolff A, Hadziselimovic F (2003) Coeliac disease. Lancet 362:1418-1419
7. Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Strom M (1996) Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci 41:83-87
8. Viljamaa M, Collin P, Huhtala H, Sievanen H, Maki M, Kaukinen K (2005) Is coeliac disease screening in risk groups justified? A 14-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther 22:317-324
9. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart DL (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, New York
10. Dube C, Rostom A, Sy R et al (2005) The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128:S57-S67
11. Hill ID (2005) What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 128:S25-S32
12. Rostom A, Dube C, Cranney A et al (2005) The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128:S38-S46
13. Rostom A, Dube C, Cranney A et al (2004) Celiac disease. Evid Rep Technol Assess (Summ) 104:1-6
14. Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH (2006) Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol 4:726-730
15. Collin P, Kaukinen K, Vogelsang H et al (2005) Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17:85-91
16. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ (2004) Is immunoglobulin a anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease? Eur J Gastroenterol Hepatol 16:467-470
17. Van Meensel B, Hiele M, Hoffman I et al (2004) Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem 50:2125-2135
18. Zintzaras E, Germenis AE (2006) Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis. Clin Vaccine Immunol 13:187-192
19. Picarelli A, Sabbatella L, Di TM et al (2000) Celiac disease diagnosis in misdiagnosed children. Pediatr Res 48:590-592
20. Clark JA, Callicoat PA, Brenner NA, Bradley CA, Smith DM Jr (1983) Selective IgA deficiency in blood donors. Am J Clin Pathol 80:210-213
21. Pereira LF, Sapina AM, Arroyo J, Vinuelas J, Bardaji RM, Prieto L (1997) Prevalence of selective IgA deficiency in Spain: more than we thought. Blood 90:893
22. Strothman R, White MB, Testin J, Chen SN, Ball MJ HLA (1986) and IgA deficiency in blood donors. Hum Immunol 16:289-294
23. Ulfarsson J, Gudmundsson S, Birgisdottir B, Kjeld JM, Jensson O (1982) Selective serum IgA deficiency in Icelanders. Frequency, family studies and Ig levels. Acta Med Scand 211:481-487
24. Koistinen J (1975) Selective IgA deficiency in blood donors. Vox Sang 29:192-202
25. Weber-Mzell D, Kotanko P, Hauer AC et al (2004) Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest 34:224-228
26. Holt PD, Tandy NP, Anstee DJ (1977) Screening of blood donors for IgA deficiency: a study of the donor population of south-west England. J Clin Pathol 30:1007-1010
27. Gudmundsson S, Jensson O (1977) Frequency of IgA deficiency in blood donors and Rh negative women in Iceland. Acta Pathol Microbiol Scand [C] 85:87-89
28. Litzman J, Sevcikova I, Stikarovska D, Pikulova Z, Pazdirkova A, Lokaj J (2000) IgA deficiency in Czech healthy individuals and selected patient groups. Int Arch Allergy Immunol 123:177-180
29. Perez Vaquero MA, Vesga Carasa MA, Lopez UA (2000) Frequency of selective IgA deficiency in Basque Country. Med Clin (Barc) 115:339-440
30. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P (1976) Endoscopic complications. Results of the 1974 American society for gastrointestinal endoscopy survey. JAMA 235:928-930
31. Newcomer MK, Brazer SR (1994) Complications of upper gastrointestinal endoscopy and their management. Gastrointest Endosc Clin N Am 4:551-570
32. Chan MF (1996) Complications of upper gastrointestinal endoscopy. Gastrointest Endosc Clin N Am 6:287-303
33. Quine MA, Bell GD, McCloy RF, Matthews HR (1995) Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg 82:530-533
34. Eisen GM, Baron TH, Dominitz JA et al (2002) Complications of upper GI endoscopy. Gastrointest Endosc 55:784-793
35. Hennekens CH, Buring JE, Mayrent SL (1987) Epidemiology in clinical medicine. Lippincott, Williams & Wilkins, Philadelphia
36. Austin GL, Shaheen NJ, Sandler RS (2006) Positive and negative predictive values: use of inflammatory bowel disease serologic markers. Am J Gastroenterol 101:413-416
37. Ramsey SD (1999) Evaluating evidence from a decision analysis. J Am Board Fam Pract 12:395-402
38. Murray JA, Green PH (1999) Biopsy is the gold standard of diagnosis of celiac sprue. Gastroenterology 116:1273-1274
39. Trier JS (1998) Diagnosis of celiac sprue. Gastroenterology 115:211-216